1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

        <em id="8sgz1"><label id="8sgz1"></label></em>
      2. <em id="8sgz1"><label id="8sgz1"></label></em>
        <em id="8sgz1"></em>
        <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

        <button id="8sgz1"></button>
        west china medical publishers
        Author
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Author "WU Yue" 5 results
        • Advantages and related developments of self-expandable valves for transcatheter aortic valve replacement

          Transcatheter aortic valve replacement is an effective treatment for aortic stenosis currently, especially in elderly, surgical high-risk, and surgical procedures-intolerant patients with severe aortic stenosis. After several generations of updates in design and function, the self-expandable valves have shown significant efficacy in treating aortic stenosis patients with bicuspid aortic valve, bioprosthetic valve failure or small annulus, and superiority in terms of valve durability, and the favorable hemodynamic outcomes could translate into clinical endpoint benefit. This literature review summarizes the advantages and recent advances of the self-expandable valves in transcatheter aortic valve replacement.

          Release date:2023-12-25 11:45 Export PDF Favorites Scan
        • Interpretation of the European Society for Vascular Surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs: Iliac vein diseases

          The European Society for Vascular Surgery (ESVS) 2022 clinical practice guidelines showed us venous thrombosis management in January 2022. In terms of iliac vein diseases, it retained some guiding views, upgraded some guiding views, and added some new views compared with the version 2015. It has good guidance and reference significance for medical staff and patients. The part of the guidelines about iliac vein disease is worth our interpretation.

          Release date:2022-12-28 06:02 Export PDF Favorites Scan
        • Research progress in adipose tissue promoted wound healing

          ObjectiveTo summarize recent progress in adipose tissue acting as a more efficient and ideal therapy to facilitate wound repair and evaluate the therapeutic values of adipose tissue.MethodsThe related literature about adipose tissue for wound healing in recent years was reviewed and analyzed.ResultsEnormous studies focus on the capacity of adipose tissue to accelerate wound healing including cellular components, extracellular matrix, and paracrine signaling have been investigated.ConclusionAdipose tissue has generated great interest in recent years because of unique advantages such as abundant and accessible source, thriven potential to enhance the regeneration and repair of damaged tissue. However, there is still a need to explore the mechanism that adipose tissue regulates cellular function and tissue regeneration in order to facilitate clinical application of adipose tissue in wound healing.

          Release date:2019-06-04 02:16 Export PDF Favorites Scan
        • Assessment of the Efficacy of Glucosamine Hydrochloride Combined with Diacerein in the Treatment of Knee Osteoarthritis with Bone Marrow Edema

          目的 研究鹽酸氨基葡萄糖聯合雙醋瑞因在伴有骨髓水腫(BME)的膝骨關節炎(KOA)中的療效評估。 方法 依據MRI檢查結果,選取2011年1月-2012年6月入院60例伴BME的KOA患者隨機分入A組(口服鹽酸氨基葡萄糖)、B組(口服雙醋瑞因)、C組(口服鹽酸氨基葡萄糖和雙醋瑞因),每組各20例;另納入同期30例不伴BME的KOA患者30例為D組(口服鹽酸氨基葡萄糖和雙醋瑞因)。完成標準方案后24周,隨訪臨床療效和影像學評分及炎癥因子變化。 結果 治療24周后4組在20 m 步行后視覺模擬評分(VAS)、關節壓痛VAS評分較治療前有改善(P<0.05);在BME改善方面,C組容積積分和程度積分均優于A、B兩組(P<0.05);在炎癥因子方面,治療24周后4組白細胞介素(IL)-1β、IL-6和腫瘤壞死因子α表達水平明顯降低(P<0.05)。 結論 鹽酸氨基葡萄糖聯合雙醋瑞因能有效改善伴有BME的KOA患者臨床癥狀、降低炎癥因子表達水平以及促進BME在影像學方面的改善。

          Release date: Export PDF Favorites Scan
        • Comparison of the Efficacy of Glucosamine Hydrochloride Combined with Anti-bone Hyperplasia Tablets in the Treatment of Different Types of Knee Osteoarthritis

          目的 研究鹽酸氨基葡萄糖聯合抗骨增生片治療膝骨關節炎(KOA)的可行性及安全性。 方法 2011年1月-2012年8月選取90例KOA患者,按關節面改變部位歸入A組(髕股關節面改變)、B組(脛股關節面改變)、C組(全關節軟骨改變),每組30例。均予以鹽酸氨基葡萄糖、抗骨增生片治療,12周后觀察治療前后臨床療效、綜合療效及安全性等指標及評分。 結果 ① 3組比較,A組療效高于B、C組(P<0.05);② A組與B、C兩組在平地行走20 m疼痛評分、關節壓痛度評分和骨關節炎指數(WOMAC)評分方面差異有統計學意義(P<0.05);③ A組和B、C兩組在患者自我療效評價、醫生療效評價方面差異有統計學意義(P<0.05);④ A組在治療12周后血液血沉、C反應蛋白(CRP)、白細胞介素(IL)-1、IL-6、腫瘤壞死因子-α(TNF-α)較治療前差異有統計表學意義(P<0.05);B組則在CRP、IL-6、TNF-α較治療前有差異(P<0.05);C組僅在CRP、TNF-α較前有差異(P<0.05);⑤3組不良反應發生率則無明顯差異(P>0.05)。 結論 鹽酸氨基葡萄糖聯合抗骨增生片治療髕股關節面改變的KOA療效優于脛股關節改變,且治療方案可行、安全、優效。

          Release date: Export PDF Favorites Scan
        1 pages Previous 1 Next

        Format

        Content

          1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

            <em id="8sgz1"><label id="8sgz1"></label></em>
          2. <em id="8sgz1"><label id="8sgz1"></label></em>
            <em id="8sgz1"></em>
            <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

            <button id="8sgz1"></button>
            欧美人与性动交α欧美精品